Sybleu Inc. (SYBE)
- Previous Close
0.0790 - Open
0.0700 - Bid --
- Ask --
- Day's Range
0.0589 - 0.0745 - 52 Week Range
0.0110 - 0.1500 - Volume
20,000 - Avg. Volume
15,531 - Market Cap (intraday)
625,665 - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and is based in Bronx, New York. As of April 15, 2024, Sybleu Inc. operates as a subsidiary of Worldwide Holdings, LLC.
Recent News: SYBE
Performance Overview: SYBE
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SYBE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SYBE
Valuation Measures
Market Cap
625.66k
Enterprise Value
1.11M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
53.49
Price/Book (mrq)
--
Enterprise Value/Revenue
95.24
Enterprise Value/EBITDA
-3.88
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-97.18%
Return on Equity (ttm)
--
Revenue (ttm)
11.7k
Net Income Avi to Common (ttm)
-307.89k
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
175
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-96.23k
Company Insights: SYBE
SYBE does not have Company Insights